ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,322.23
0.45%
Dow Jones
42,584.62
0.97%
Gold vs US Dollar
2,652.795
-0.74%
Brent Oil
71.045
0.13%
Bitcoin
66,279.54
1.68%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evolus Inc (EOLS)

  7. Evolus Inc (EOLS) News

Evolus (EOLS)

Evolus Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EOLS
DateTimeSourceHeadlineSymbolCompany
07/09/202402:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
07/09/202402:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
06/09/202413:00Business WireEvolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024NASDAQ:EOLSEvolus Inc
04/09/202421:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/08/202421:30Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
31/07/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
31/07/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
31/07/202421:05Business WireEvolus Reports Second Quarter 2024 Results and Raises Full Year Revenue GuidanceNASDAQ:EOLSEvolus Inc
31/07/202413:00Business WireEvolus to Hold Investor Day on September 12, 2024NASDAQ:EOLSEvolus Inc
30/07/202413:00Business WireEvolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in AustraliaNASDAQ:EOLSEvolus Inc
25/07/202413:00Business WireEvolus to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:EOLSEvolus Inc
17/07/202413:00Business WireEvolus to Report Second Quarter Financial Results on July 31, 2024NASDAQ:EOLSEvolus Inc
01/07/202413:00Business WireEvolus Announces Appointment of Albert G. White III to Board of DirectorsNASDAQ:EOLSEvolus Inc
24/06/202413:00Business WireEvolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler ProductsNASDAQ:EOLSEvolus Inc
12/06/202413:00Business WireEvolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in SpainNASDAQ:EOLSEvolus Inc
11/06/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
07/06/202422:00Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
07/06/202400:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
06/06/202422:45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
06/06/202402:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
05/06/202422:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
04/06/202421:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
03/06/202422:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
20/05/202413:30Business WireEvolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE MeetingNASDAQ:EOLSEvolus Inc
15/05/202422:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
15/05/202413:30Business WireEvolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO SummitNASDAQ:EOLSEvolus Inc
15/05/202401:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
15/05/202401:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
15/05/202401:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
10/05/202423:55Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
 Showing the most relevant articles for your search:NASDAQ:EOLS

Your Recent History

USOTC
PSGFF
Precious Shipping Pl (PK)
NASDAQI
HURNTR
ISE Cyber Security UCITS...
AMEX
EWGS
iShares MSCI Germany Sma...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved